Artelo Biosciences Inc (ARTL)

Currency in USD
9.0300
+0.0300(+0.33%)
Closed·
After Hours
9.3500+0.3200(+3.54%)
·
ARTL Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ARTL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
8.91509.2500
52 wk Range
4.917628.6000
Key Statistics
Prev. Close
9
Open
9.18
Day's Range
8.915-9.25
52 wk Range
4.9176-28.6
Volume
14.2K
Average Volume (3m)
659.42K
1-Year Change
13.16%
Book Value / Share
1.19
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ARTL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
18.0000
Upside
+99.34%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Artelo Biosciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Artelo Biosciences Inc Company Profile

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company’s product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated/ weight loss with cancer; and ART12.11, a synthetic cannabidiol cocrystal for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, pain and inflammation, and other potential indications. It also offers ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

Compare ARTL to Peers and Sector

Metrics to compare
ARTL
Peers
Sector
Relationship
P/E Ratio
−0.6x−0.4x−0.5x
PEG Ratio
−0.130.020.00
Price/Book
9.4x2.6x2.6x
Price / LTM Sales
-1.5x3.3x
Upside (Analyst Target)
100.0%221.3%43.4%
Fair Value Upside
Unlock28.8%7.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 18.0000
(+99.34% Upside)

Earnings

Latest Release
Aug 06, 2025
EPS / Forecast
-- / -0.1265
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ARTL Income Statement

People Also Watch

41.28
BMNR
+7.30%
5.6600
BGLC
0.00%
2.070
VOR
-0.96%
17.96
SRPT
+10.46%
7.120
TRON
+3.94%

FAQ

What Stock Exchange Does Artelo Biosciences Trade On?

Artelo Biosciences is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Artelo Biosciences?

The stock symbol for Artelo Biosciences is "ARTL."

What Is the Artelo Biosciences Market Cap?

As of today, Artelo Biosciences market cap is 6.27M.

What Is Artelo Biosciences's Earnings Per Share (TTM)?

The Artelo Biosciences EPS (TTM) is -17.97.

When Is the Next Artelo Biosciences Earnings Date?

Artelo Biosciences will release its next earnings report on 05 Aug 2025.

From a Technical Analysis Perspective, Is ARTL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Artelo Biosciences Stock Split?

Artelo Biosciences has split 3 times.

How Many Employees Does Artelo Biosciences Have?

Artelo Biosciences has 5 employees.

What is the current trading status of Artelo Biosciences (ARTL)?

As of 08 Aug 2025, Artelo Biosciences (ARTL) is trading at a price of 9.03, with a previous close of 9.00. The stock has fluctuated within a day range of 8.92 to 9.25, while its 52-week range spans from 4.92 to 28.60.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.